Related Experiment Video
Updated: Sep 19, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Development Of the VAMPCT Score for Predicting Mortality in CKD Patients with COVID-19
Chaofan Li1, Yue Niu1, Xinyan Pan2
1Department of Nephrology, First Medical Center of Chinese PLA General Hospital, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Medical Devices and Integrated Traditional Chinese and Western Drug Development for Severe Kidney Diseases, Beijing Key Laboratory of Digital Intelligent TCM for the Prevention and Treatment of Pan-vascular Diseases, Key Disciplines of National Administration of Traditional Chinese Medicine (zyyzdxk-2023310), Beijing 100853, China.
Insights
A new machine learning score, VAMPCT, accurately predicts COVID-19 mortality in chronic kidney disease (CKD) patients. This tool aids in identifying high-risk individuals for better clinical management.
Area of Science:
- Nephrology
- Infectious Diseases
- Artificial Intelligence in Medicine
Background:
- Patients with chronic kidney disease (CKD) face elevated mortality risk from coronavirus disease 2019 (COVID-19).
- Current methods for identifying high-risk CKD patients with COVID-19 are suboptimal.
- There is a need for improved clinical tools to predict mortality in this vulnerable population.
Purpose of the Study:
- To develop and validate a machine learning (ML)-based score for predicting acute COVID-19 mortality in CKD patients.
- To identify key clinical and laboratory factors associated with mortality in this cohort.
- To create a user-friendly scoring system for clinical application.
Main Methods:
- Prospective enrollment of 219 CKD inpatients with COVID-19 from December 2022 to January 2023.
- Feature selection using least absolute shrinkage and selection operator (LASSO) and stepwise methods.
- Development and comparison of ML models including logistic regression, SVM, random forest, and XGBoost.
- Construction of a predictive score based on logistic regression using identified key factors.
Main Results:
- The study included 219 CKD patients with a high mortality rate of 25.1%.
- The Support Vector Machine (SVM) model demonstrated strong predictive performance (AUC 0.946).
- The developed VAMPCT score, incorporating COVID-19 vaccination status, age, monocyte percentage, prothrombin activity, cardiac troponin T, and total bilirubin, achieved a high AUC of 0.960 for predicting 3-month mortality.
Conclusions:
- Machine learning models show excellent performance in predicting 3-month mortality for CKD patients with COVID-19.
- The VAMPCT score offers a clinically practical and accurate method for risk stratification.
- This tool can aid clinicians in managing high-risk CKD patients during the COVID-19 pandemic.
Abstract:
Background: Chronic kidney disease (CKD) patients with coronavirus disease 2019 (COVID-19) are at significant risk of death. However, clinical identification of high-risk individuals remains suboptimal despite the recognition of many pathophysiological and comorbidity-related risk factors. We aim to develop a clinically simple machine learning (ML)-based score to predict acute COVID-19 mortality among CKD patients. Methods: CKD inpatients with COVID-19 were prospectively enrolled from December 2022 to January 2023 with a three-month follow-up. Feature selection from clinical and laboratory results was performed through least absolute shrinkage and selection operator and stepwise selection. Logistic regression, support vector machine (SVM), random forest, and extreme gradient boosting were applied for ML model development. A predictive score for mortality was constructed using logistic regression. We compared predictive ability between the proposed score and other published scores. Results: 219 CKD patients were included and had a high mortality rate of 25.1%. The SVM model exhibited the best performance, with the validation area under the receiver operating characteristic curve (AUC) being 0.946 (95% CI 0.918, 0.974). The COVID-19 vaccination status, age, monocyte percentage, prothrombin activity, cardiac troponin T, and total bilirubin ("VAMPCT") were the most relevant factors and utilized to develop the scoring system with an AUC of 0.960 (95% CI 0.935, 0.985). Conclusion: ML models predicting three-month mortality had favorable performance for CKD patients with COVID-19. The VAMPCT mortality score provided a user-friendly approach.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Chronic Kidney Disease I: Introduction

